Wei-Ru Xu
Impact in
-
- Acupuncture Treatment Research Studies
- Complementary and Alternative Medicine Studies
- Traditional Chinese Medicine Studies
-
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 5
- Cancer Cells and Metastasis 2
- Cancer-related Molecular Pathways 2
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Guowang Yang (7 shared papers)Xiao-min Wang (7 shared papers)Mingwei Yu (7 shared papers)Hongsheng Lin (2 shared papers)Wei Hou (2 shared papers)Xiaoyun Zhu (3 shared papers)Ying Zhang (2 shared papers)Xin Qi (3 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Trials (2 papers)Evidence-based Complementary and Alternative Medicine (1 paper)Complementary Therapies in Medicine (1 paper)Medical Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Wei-Ru Xu
14 papers receiving 331 citations
Peers
Comparison fields: 5 of 60
- Complementary and alternative medicine 52
- Oncology 100
- Pharmacology 29
- Toxicology 11
- Cancer Research 35
Countries citing papers authored by Wei-Ru Xu
This map shows the geographic impact of Wei-Ru Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Ru Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Ru Xu more than expected).
Fields of papers citing papers by Wei-Ru Xu
This network shows the impact of papers produced by Wei-Ru Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Ru Xu. The network helps show where Wei-Ru Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-Ru Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 66 | |
| 2 | 2011 | 59 | |
| 3 | 2015 | 48 | |
| 4 | [Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs]. | 2010 | 37 |
| 5 | 2014 | 37 | |
| 6 | 2020 | 34 | |
| 7 | 2017 | 17 | |
| 8 | 2017 | 13 | |
| 9 | 2011 | 11 | |
| 10 | 2017 | 10 | |
| 11 | 2011 | 4 | |
| 12 | 2014 | 3 | |
| 13 | [Oxymatrine Diminished the Side Population and Inhibited Wnt/p-catenin Signaling Pathway in MCF- 7 Breast Cancer Cells]. | 2016 | 1 |
| 14 | 2025 | 1 | |
| 15 | 2025 | 0 |
About Wei-Ru Xu
Wei-Ru Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Toxicology, Otorhinolaryngology and Molecular Biology, having authored 15 papers that have together received 341 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Cancer-related Molecular Pathways (2 papers), Nausea and vomiting management (2 papers), Lung Cancer Treatments and Mutations (2 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (1 paper), Head and Neck Cancer Studies (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Complementary and alternative medicine (52 citations), Oncology (100 citations), Pharmacology (29 citations), Toxicology (11 citations) and Cancer Research (35 citations). Wei-Ru Xu has collaborated with scholars based in China. Frequent co-authors include Guowang Yang, Xiao-min Wang, Mingwei Yu, Hongsheng Lin, Wei Hou, Xiaoyun Zhu, Ying Zhang, Xin Qi, Baojin Hua and Wei Hou. Their work appears in journals such as Frontiers in Oncology, Trials, Evidence-based Complementary and Alternative Medicine, Complementary Therapies in Medicine and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.